“I'm honored to be working with the Tempus team as they advance innovative tools for personalizing patient care and empower providers with information that can help them make better and more informed treatment decisions for their patients.”

Scott Gottlieb, MD, Scientific Advisor

Wayne A. I. Frederick, MD, MBA

“As a surgical oncologist, I have worked to reduce racial, ethnic and gender health care disparities throughout my career. Tempus is a leader in the field of data-driven medicine, and I am excited to work with their team to further enhance patient outcomes for individuals of all backgrounds and from all communities.”

Wayne A. I. Frederick, MD, MBA, Charles R. Drew Professor of Surgery

Peter Barris

“We are thrilled to have led an investment in Tempus... Given NEA's long and successful history investing in the intersection of technology and life science, we felt like the perfect strategic partner given Tempus' mission to help doctors personalize care by collecting and analyzing large volumes of data.”

Peter Barris, Chairman & General Partner, New Enterprise Associates

Ted Leonsis

“Having spent my entire career at the forefront of emerging technologies, it’s exciting to see how healthcare is finally embracing the very technologies that have transformed so many other industries. This is a space that is near and dear to me, and I'm excited to be a part of Tempus as they seek to bring big data, artificial intelligence and advanced molecular analysis to those suffering with cancer and other life threatening diseases.”

Ted Leonsis, Cofounder & Partner, Revolution Growth

Jennifer Doudna

“I look forward to working with the Tempus team as they continue to apply technology and artificial intelligence to healthcare, deploying intelligent diagnostics that enhance research, empower physicians, and positively change the lives of patients.”

Jennifer Doudna, PhD, Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley